Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Add filters

Year range
Braz. J. Pharm. Sci. (Online) ; 56: e18575, 2020. tab, graf
Article in English | LILACS | ID: biblio-1285517


Buccal route of administration has many advantages such as improving patient compliance, bypassing the GIT and hepatic first pass effect. The objectives are to formulate mucoadhesive buccal tablet using Mefenamic acid and compatible excipients, and to evaluate the product using quality control tests and in vitro tests. The ingredients were subjected to Differential Scanning Calorimetry and Fourier Transform Infrared Spectroscopy studies for compatibility test and the results showed no interaction. Two batches of mefenamic buccal tablet were prepared. The tablet thickness and diameter are 3.75 mm and 12 mm respectively. All tablets are within the specification of +/- 5%. The in-house tablet hardness is 6.8-15kg and percent friabilation is not more than 0.8%. The disintegration test showed that all tablets disintegrated within 4 hours. The content uniformity showed that tablets are within the range of 85%-115%. The tablet weight is within the 5% range. The percent swelling is 53.83% to 58.86% and moisture absorption is 14.79% to 15.56%. The surface pH of the tablet is close to the salivary pH, which means that it would not irritate the buccal mucosa. The buccal tablet has a mucoadhesiveness of 0.196 to 0.200. There was no change in pH and size after subjecting it to stability studies in human saliva. Drug release studies showed 80.7% to 83.4% after 3 hours. Even after 3 months of subjecting the tablets to 40 ºC and 75% RH, results are within acceptable range. The results show the potential of the formulation as a mucoadhesive buccal tablet.

Mefenamic Acid/analysis , Mouthwashes/analysis , Quality Control , Tablets/pharmacology , Calorimetry, Differential Scanning/methods , Spectroscopy, Fourier Transform Infrared/methods
Braz. J. Pharm. Sci. (Online) ; 55: e17870, 2019. tab, graf
Article in English | LILACS | ID: biblio-1039075


Mefenamic acid (MFA) is a hydrophobic drug with low dissolution rate. This study aimed to develop stable and reproducible aqueous formulations of MFA using liposomes as drug carriers. The drug entrapment, particles size and drug release profiles, and stability and reproducibility of the liposomes were determined. In addition, the maximum tolerated dose (MTD) was determined in rats via the oral and intraperitoneal routes of administration. Also, the anti-inflammatory efficacy of these liposomes was evaluated using carrageenan-induced paw edema model in rats. MFA-DDC based liposomes demonstrated a drug entrapment efficacy of 93.6%, particles size of 170.9 nm, and polydispersity index of 0.24 which were not statistically affected when stored in room and refrigerated temperatures for at least 4 weeks. The MTD of the intraperitoneally administrated MFA-loaded liposomes was 20 mg MFA/kg, whereas for those of oral administrations, it was up to 80 mg MFA/kg. Intraperitoneal dose (80 mg MFA/kg) of MFA-DDC liposomes induced extrapyramidal symptoms associated with significant elevation in serum potassium and muscle enzymes. Moreover, significant inhibition of paw edema was demonstrated by the oral and intraperitoneal routes. These findings suggest that MFA-DDC based liposomes are an effective formulation of MFA and recommend the use of bioequivalence assessments with commercial formulations.

Animals , Female , Rats , Mefenamic Acid/analysis , Ditiocarb/analysis , Liposomes/agonists , In Vitro Techniques , Carrageenan
Egyptian Journal of Pharmaceutical Sciences. 1996; 37 (1-6): 157-174
in English | IMEMR | ID: emr-40788


This paper described two new colorimetric methods for estimation of six nonsteroidal anti-inflammatory drugs; namely, piroxicam, tenoxicam, mefenamic acid, flufenamic acid, ibuprofen and ketoprofen in their pure forms and pharmaceutical preparations. The first method depends on scanning the azodyes resulting from the reaction of piroxicam and tenoxicam with diazonium salts of benzocaine, p-amino-N- methylbenzamide and sulfadiazine. The second procedure is based on colorimetric determination of the blue colored complexes yielded from the reaction of methylene blue with drugs under investigation. The different conditions for the proposed methods were studied. The methods have been applied for the analysis of pharmaceutical preparations containing these drugs and the results obtained were compared with those of pharmacopoeial or published methods. The methods are simple, precise and reproducible

Colorimetry/methods , Piroxicam/analysis , Mefenamic Acid/analysis , Flufenamic Acid/analysis , Ibuprofen/analysis , Ketoprofen/analysis
Egyptian Journal of Pharmaceutical Sciences. 1987; 28 (1-4): 203-14
in English | IMEMR | ID: emr-8716